ConductScience.org, home

Gene · 80331

Papers3,340

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

1,901 to 1,920 of 3,340

Download this page as JSON
TitleJournalYearPMIDFound bySource
A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII.Vaccine201729089194PubTator, text miningPubMed
Predicting local malaria exposure using a Lasso-based two-level cross validation algorithm.PLoS One201729088280PubTator, text miningPubMed
Production of bioactive liver-targeting interferon Mu-IFN-CSP by soluble prokaryotic expression.AMB Express201729086199PubTator, text miningPubMed
Mitochondrial genome of Plasmodium vivax/simium detected in an endemic region for malaria in the Atlantic Forest of Espírito Santo state, Brazil: do mosquitoes, simians and humans harbour the same parasite?
Malar J201729084553PubTator, text miningPubMed
A β-Carbon elimination strategy for convenient in situ access to cyclopentadienyl metal complexes.Chem Sci201729081949PubTator, text miningPubMed
γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations.J Immunol201729079696PubTator, text miningPubMed
Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite.Front Immunol201729075260PubTator, text miningPubMed
Antitumor activities of Liver-targeting peptide modified Recombinant human Endostatin in BALB/c-nu mice with Hepatocellular carcinoma.Sci Rep201729075040PubTator, text miningPubMed
Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity.Nat Commun201729074880PubTator, text miningPubMed
Conditional knockout tools: Application of site-specific incorporation of unnatural amino acid via genetic code expansion in viral and parasite vaccine development.Synth Syst Biotechnol201729062955PubTator, text miningPubMed
Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area.
Am J Trop Med Hyg201729016339PubTator, text miningPubMed
Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS.Cell Rep201728978466PubTator, text miningPubMed
On the Catalytic Activity of Pt Supported by Graphyne in the Oxidation of Ethanol.ChemistrySelect201728966970PubTator, text miningPubMed
Identification of miRNA-mRNA Network Associated with Acute Myeloid Leukemia Survival.Med Sci Monit201728965123PubTator, text miningPubMed
Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens.Malar J201728962616PubTator, text miningPubMed
DAF-shielded baculovirus-vectored vaccine enhances protection against malaria sporozoite challenge in mice.Malar J201728962615PubTator, text miningPubMed
Identification of highly-protective combinations of Plasmodium vivax recombinant proteins for vaccine development.Elife201728949293PubTator, text miningPubMed
Profiling the Targets of Protective CD8+ T Cell Responses to Infection.Mol Ther Methods Clin Dev201728948187PubTator, text miningPubMed
Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection.PLoS Negl Trop Dis201728938005PubTator, text miningPubMed
Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection.NPJ Vaccines201728936360PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/80331/papers?page=96